Azelexin

Quick links to important sections

Azelexin

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azelexin

Property Description
Active ingredient Azelaic Acid (Nonanedioic acid)
Form Cream or Gel, for external use
Pharmacological class Topical Anti-acne Agent, Antikeratinizing Agent
Common use Management of Acne Vulgaris
Origin Synthetically produced dicarboxylic acid

Azelexin is a prescription medication applied directly to the skin, classified as a topical anti-acne agent and belonging to the dicarboxylic acid group. The active compound is Azelaic Acid (INN), a nine-carbon acid that is synthetically produced for pharmaceutical preparations to guarantee consistency, despite being structurally related to compounds found naturally in grains. Azelexin is typically available as a cream or a gel, both designed for cutaneous application as a single-ingredient product.


Composition and General Therapeutic Purpose

Azelexin is specifically classified as an antikeratinizing agent and a comedolytic because its core function involves normalizing skin cell growth to prevent the formation of blocked pores. The general therapeutic purpose of Azelaic Acid is the comprehensive management of acne vulgaris by targeting multiple underlying causes of the condition. The triple action of the compound is clinically recognized for its efficacy: it exerts a bacteriostatic effect against acne-causing bacteria, it provides a distinct anti-inflammatory action to lessen redness and swelling, and it has a significant comedolytic action to help keep pores clear. This evidence-supported, multi-modal capability distinguishes Azelaic Acid, allowing it to address the mixed presentation of inflammatory lesions and non-inflammatory lesions common in adolescent and adult acne, offering a broad-spectrum management approach.

What side effects are possible with Azelexin?

Possible side effects and safety information

The safety profile of topical Azelaic Acid (Azelexin) is characterized primarily by adverse reactions occurring at the application site, as documented in official regulatory sources. These effects are formally classified by frequency, with the majority falling into the high-incidence categories.

Frequency-Classified Adverse Reactions

The most frequent reactions are classified as Very Common (ge 1/10) or Common (ge 1/100 to < 1/10).

Classification Examples of Reactions (SOC: Skin/Application Site)
Very Common Pruritus (itching), burning, erythema (redness), and local pain
Common Dryness, scaling, local irritation, and paraesthesia (tingling/numbness)

Reactions classified as Uncommon (ge 1/1,000 to < 1/100) include eye irritation and contact dermatitis. Rare (ge 1/10,000 to < 1/1,000) documented reactions include instances of hypersensitivity, rash, and depigmentation.

Time-Related Patterns and Safety Constraints

The frequency and intensity of local skin reactions, such as stinging and burning, are officially noted to be more frequently observed at the beginning of treatment and generally diminish as therapy progresses.

Regulatory safety information highlights the potential for hypersensitivity reactions (e.g., angioedema), which, though rare, represent the primary systemic safety concern. The product is strictly for external use, and contact with the eyes, mouth, and other mucous membranes must be avoided due to the potential for severe local irritation. Additionally, patients with darker skin tones must be monitored for changes in skin color, as the medication may cause hypopigmentation.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for topical Azelaic Acid indicates that systemic overdose is highly unlikely. This is due to the drug's minimal percutaneous absorption and low systemic toxicity when applied to the skin as directed. Acute intoxication is not expected to occur from a single application over a large area.

The primary situation that requires immediate attention is the accidental oral ingestion of the Azelexin product. Should suspected ingestion occur, the official regulatory documents mandate that users must seek immediate medical attention or contact a Poison Control center for guidance. This is the explicitly defined circumstance that triggers the requirement for urgent external help.

Management of an overdose event is restricted to providing symptomatic and supportive treatment, as regulatory texts confirm that no specific antidote is known for Azelaic Acid. No specific severe systemic outcomes are documented as expected consequences of overdose in the official prescribing information.

In the event of accidental contact with mucous membranes, such as the eyes, the affected area must be washed thoroughly with water. A physician should be consulted if any irritation persists following this action.

Therapeutic Uses of Azelexin

Azelaic Acid (Azelexin) is commonly used for managing conditions presenting with systemic or localized discomfort. The primary indications are established for clinical use. It is applied across domains where additional symptomatic support is needed for both acne vulgaris and the inflammatory symptoms of rosacea.


Therapeutic Uses and Symptom Management

The medication is relevant for easing symptoms associated with conditions involving inflammatory or irritative states. It is applied in addressing the symptom clusters of mild-to-moderate acne, encompassing both inflammatory lesions like papules and pustules, and non-inflammatory lesions such as blackheads and whiteheads. It is relevant for easing symptoms that interfere with daily comfort, particularly pigmentary concerns like post-inflammatory hyperpigmentation (PIH).

This approach supports patients during difficult episodes by easing distress related to appearance and helps address symptom clusters that may become disruptive.

“It is relevant for easing symptoms that become more disruptive during flare-ups and contributes to easing the overall symptom load.”


Quick Fact

Quick Fact: Relief for Key Symptoms
Conditions Acne Vulgaris, Papulopustular Rosacea, Post-Inflammatory Hyperpigmentation
Symptom Focus Lesions and blemishes, facial redness (erythema), Inflammation and redness, and post-blemish discoloration
Patient Benefit Supports general well-being and Contributes to improved day-to-day comfort during symptomatic periods

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Azelexin

The eligibility profile for Azelaic Acid is defined by regulatory bodies (e.g., FDA, EMA) based on absolute contraindications and population-specific restrictions.

Category Official Regulatory Statement
Contraindicated Populations Individuals with known hypersensitivity to Azelaic Acid or any component (excipient) of the specific topical formulation must not use the medicine.
Age Eligibility Use is established for adults and adolescents aged 12 years and older for acne vulgaris. Safety and efficacy are not established for children under 12.
Pregnancy and Lactation Pregnancy: Use is conditional and only permitted if clearly needed. Lactation: Use requires caution; the infant must not contact the treated skin area or breast.
Conditional Restrictions Patients with dark complexions must be monitored for early signs of hypopigmentation. Patients with asthma must be aware of reports of condition exacerbation.

The eligibility rules fundamentally establish a clear boundary for use: while permissible for the labeled indications in adults and older adolescents, use is strictly prohibited based on hypersensitivity and remains unestablished for young children. This framework dictates who is officially eligible for treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Azelaic Acid (Azelexin) indicates that systemic drug-drug interactions are not expected. This assessment is based on the low percutaneous absorption of the active ingredient, as only minimal amounts (approximately 4% of a topical dose) reach the systemic circulation. Regulatory documents confirm that formal studies of interaction with other systemic medicines have not been conducted.

Documented Interaction Restrictions

Interaction constraints are primarily focused on the site of application and the underlying condition being managed. These restrictions define the product's official interaction profile, as listed in regulatory summaries:

Interaction Type Official Regulatory Statement
Systemic Drug-Drug None documented. Systemic interactions are not anticipated because plasma levels remain within the endogenous range.
Local Pharmacodynamic Co-application restriction: Use with topical substances such as alcoholic cleansers, astringents, abrasives, or peeling agents is restricted due to the risk of additive local irritation.
Substance Interaction Avoidance of Triggers: For the management of rosacea, patients are advised to avoid alcoholic beverages, spicy foods, and thermally hot foods and drinks, as these substances are known to trigger flare-ups of the condition.

No specific drug combinations are formally listed as contraindicated, nor are any timing separation rules documented for the co-administration of oral medicinal products. The profile is therefore defined by local restrictions rather than systemic pharmacokinetic effects.

Mechanism of Action

How Azelexin Works: Pharmacodynamic Mechanisms

Azelaic Acid operates via a simultaneous triple-mechanistic action that modulates key physiological processes within the skin. First, it exerts an antiproliferative effect on hyperactive keratinocytes by inhibiting their mitochondrial enzymes, thereby suppressing DNA and protein synthesis. This mechanism normalizes the abnormal maturation of cells lining the hair follicle, a key physiological change that minimizes the accumulation of cellular material contributing to follicular plugging.

Second, the molecule is bacteriostatic against targeted skin bacteria, such as Cutibacterium acnes, by disrupting their cellular respiration and protein synthesis, resulting in the suppression of microbial proliferation and reduced colony counts. Third, it acts as an anti-inflammatory modulator by directly scavenging Reactive Oxygen Species (ROS) and reducing the expression of the protease Kallikrein 5 (KLK5), thereby reducing the generation of pro-inflammatory peptides. This multifaceted activity results in the concurrent regulation of cell kinetics, microbial density, and localized inflammation.

Dosage and Administration Information

Azelexin is administered strictly via the topical route to the affected areas of the skin, as it is formulated exclusively for dermatologic use and is not for internal consumption. The standard application frequency for the medication, available as 15% gel/foam or 20% cream, is twice daily (morning and evening). A thin layer sufficient only to cover the entire affected area should be applied.

Before application, the skin must be thoroughly cleansed with a mild, soapless lotion and then patted dry. After use, instructions generally specify immediate handwashing. The medication is typically used as a continuous course; optimal outcomes are commonly observed after several months of consistent application. Treatment is typically reassessed if no improvement is observed after 12 continuous weeks.

Usage rules define specific procedural constraints: the use of occlusive dressings or wrappings over the treated area is explicitly forbidden. Furthermore, patients should avoid using alcoholic cleansers, astringents, abrasives, or peeling agents on the treated skin. The medication's use for acne is indicated for patients 12 years of age and older. Dosing generally does not require adjustment for older adults due to minimal systemic absorption.

Recent Clinical Evidence

Research evidence / Overview of studies for Azelexin

This section outlines the research that has explored the use of Azelaic Acid for approved conditions, describing the types of studies conducted and where the limits of the current evidence lie. It does not offer clinical advice or personal recommendations.


Evidence for Use in Acne Vulgaris

The research for Azelaic Acid in acne vulgaris is based on multiple Randomized Controlled Trials (RCTs) and systematic reviews, primarily focusing on adolescents and adults with mild-to-moderate forms. Research examined outcomes related to lesion counts (inflammatory and non-inflammatory). Studies reported patterns related to these measured outcomes during the study period. Comparator studies were conducted against other topical agents and a non-active vehicle; results varied among comparisons. Evidence for long-term maintenance is a key uncertainty.


Evidence for Use in Papulopustular Rosacea

For papulopustular rosacea, the core evidence comes from multiple Randomized Controlled Trials. These studies monitored the number of inflammatory lesions (papules and pustules) and associated redness over the typical 12-week trial duration. Findings describe patterns related to the outcomes assessed. What is still uncertain is the characterization of long-term outcomes and the durability of response beyond the acute phase.


Evidence in Specific Contexts and Research Gaps

Azelaic Acid was studied for post-inflammatory hyperpigmentation (PIH) in RCTs and pilot studies, and trials described measured changes in pigmentation severity. However, evidence for this application is limited. Research has also explored long-term use and included specific populations, such as adolescents and patients with darker skin tones (Phototypes III-VI).

Nonetheless, data on multi-year continuous use are not fully established. Furthermore, data for certain groups (such as older adults or pregnant populations) remain insufficient, representing key research gaps. Evidence quality varies across studies, and results apply only to the specific conditions under which they were conducted.

Key Studies & References Azelaic Acid Topical - NIH MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Azelexin (FAQ)


Q: How long does Azelexin stay in your system after you stop taking it?

According to official product information, only minimal amounts of the active ingredient are absorbed into the body when applied to the skin. This small amount is then eliminated. Studies indicate the half-life of the active ingredient in the body is approximately 12 hours after topical application.


Q: Are there any known long-term side effects of taking Azelexin?

The most common adverse reactions reported are generally mild and transient local skin effects, such as burning or itching. Official documents indicate these reactions generally lessen as therapy progresses. Official research evidence currently indicates that data regarding the effects and safety of continuous use over multiple years are not fully established.


Q: Is Azelexin a type of antibiotic?

Azelexin is chemically classified by regulatory bodies as a dicarboxylic acid. It has an anti-acne function that involves multiple mechanisms of action. One of these actions is described as bacteriostatic, meaning it inhibits the growth of acne-causing bacteria on the skin.


Q: Is Azelexin approved for treating conditions other than [Main Indication]?

Official regulatory documents list the approved uses for this medication. It is approved only for the topical management of mild-to-moderate inflammatory acne vulgaris and the papules and pustules associated with mild to moderate rosacea.


Q: Does Azelexin contain any common allergens, like gluten or lactose?

Official labeling lists all inactive components (called excipients) used in the formulation, such as propylene glycol and certain alcohols. Standard regulatory descriptions focus on listing all inactive components present, rather than listing components that are absent.


Q: What are the safety concerns related to combining Azelexin with alcohol?

Official regulatory information addresses two types of potential interaction involving alcohol. Using topical products like alcoholic cleansers is restricted because of the risk of causing more local skin irritation. For patients with rosacea, alcoholic beverages are advised to be avoided because they are known triggers that can cause a flare-up of the condition.


Q: Is Azelexin a lifelong treatment or is it usually for a short time?

The duration of treatment depends on the condition being managed. For acne, the usual course can be up to six months, though official documents note that longer treatment may be required for control. For rosacea, the medication is often used as a continuous, long-term treatment.


Q: Does Azelexin start working immediately after the first dose?

While treatment must be consistent from the start, a noticeable change or improvement is typically not immediate. Official studies indicate that improvement is usually first detectable within one to two months. The maximum therapeutic benefit may require a more prolonged and consistent course of treatment.


Q: Can Azelexin cause tiredness or drowsiness?

The known adverse reactions reported in regulatory documents are overwhelmingly local skin reactions such as burning, itching, or redness. Systemic effects that could cause issues like tiredness or drowsiness are not listed in the official safety information for the topical formulation.


Q: Is it common to have a dry mouth when taking Azelexin?

Official regulatory documents classify adverse reactions by frequency. Dry mouth is not listed as a common or rare adverse reaction associated with the topical formulation.


Q: Do I need to change my diet while using Azelexin?

A general diet change is typically not required when using this medication. However, official information for rosacea management specifically advises patients to avoid known flare-up triggers, such as alcoholic beverages, spicy foods, and thermally hot foods and drinks.


Q: Are there any specific supplements that should not be taken with Azelexin?

Due to the very minimal systemic absorption of the active ingredient (only about 4% of the topical dose), regulatory documents state that no systemic drug-drug or supplement interactions are expected. Therefore, no specific interactions with supplements are reported in the clinical trials.


Q: Is there a generic version of Azelexin available?

The medication's active ingredient is Azelaic Acid, which is available in various concentrations and forms (creams, gels, and foams) from different manufacturers. Azelaic Acid is therefore available as a generic topical product in many regions.


Q: What happens if I miss a dose of Azelexin?

Official regulatory instructions describe that if a scheduled dose is missed, it should be skipped. The individual should return to the regular application schedule at the next designated time. Official instructions note that more product is not applied to compensate for the missed dose.


Q: Does Azelexin affect birth control pills?

Since the systemic absorption of the topical medication is very low, official documents indicate that no specific systemic drug-drug interaction with oral contraceptives (birth control pills) is anticipated or reported.


Q: Is Azelexin addictive or habit-forming?

The medication is not classified as a controlled substance by regulatory agencies. Therefore, it is not considered to be addictive or habit-forming.


Q: Why do some people say Azelexin made them feel jittery?

Adverse reactions reported for the topical product are mainly localized to the skin. Systemic effects such as feeling jittery or nervous are not listed in the official adverse reactions reported in regulatory documents for the topical formulation.


Q: Is Azelexin considered a controlled substance?

Azelexin is a prescription medication, but it is not classified as a controlled substance by regulatory agencies.


Q: Can I drink coffee or caffeine while using Azelexin?

Official information does not restrict caffeine itself. However, patients managing rosacea are advised to avoid consuming thermally hot drinks (such as hot coffee or tea) because these substances are known triggers that can cause rosacea flare-ups.


Q: Can Azelexin affect my ability to drive or operate machinery?

The known adverse reactions are predominantly local skin effects. Regulatory documents state that adverse reactions reported are predominantly local and do not typically include central nervous system effects.


Q: Is it normal to feel a mild headache when first starting Azelexin?

The most commonly reported reactions are skin-related, such as local burning and itching. Headache is not listed as a common or rare adverse reaction in regulatory documents for the topical formulation.


Q: Are there any specific blood tests required before starting Azelexin?

Regulatory documents do not state that individuals need to undergo specific blood tests before initiating treatment with the topical formulation of this medication.


Q: Do regulatory agencies have a black box warning associated with Azelexin?

The official regulatory labels and warnings associated with this medication do not include a Black Box Warning.


Q: Can using Azelexin affect my blood pressure?

The adverse reactions reported in regulatory documents are mainly localized to the application site. Changes in blood pressure are not listed among the reported adverse reactions for the topical formulation.


Q: Can Azelexin cause changes in mood or anxiety levels?

The known adverse reactions are primarily local skin effects. Adverse reactions that include changes in mood or anxiety levels are not typically reported in regulatory documents for the topical formulation.


Q: Does the package insert for Azelexin mention weight gain or loss?

Weight gain or loss are not listed among the reported adverse reactions in the regulatory documents for the topical formulation of the medication.


Q: Can I take Azelexin if I have a history of kidney problems?

Official information notes that systemic absorption is very low (about 4% of the topical dose). Since the drug is mostly excreted unchanged, specific precautions or dose adjustments related to kidney function are generally not specified in the product labeling.


Q: What information is available regarding Azelexin use in people with liver conditions?

Because the topical formulation has minimal systemic absorption into the bloodstream, specific precautions or dose adjustments related to liver function are generally not specified in the product labeling.


Q: How soon after stopping other medicines can I start Azelexin?

Official regulatory information does not document formal timing separation rules for starting this medication after stopping other systemic medicines.


Q: Can Azelexin cause sun sensitivity?

The official warnings and precautions for the topical medication do not list sun sensitivity, also known as photosensitivity, as a known adverse effect or required precaution.

How should Azelexin be stored and disposed of?

Storage and Disposal Requirements for Azelex (Azelaic Acid Cream)

Azelex must be stored at controlled room temperature, maintaining a range of 15 C to 30 C (59 F to 86 F). It is essential to protect the cream from freezing and store it in a closed container, away from excess heat and moisture. Storage must be out of the reach of children.

Handling and Disposal

Official labeling for similar products indicates an in-use shelf life of 6 months after first opening. When disposing of unused or expired medicine, individuals should consult a healthcare professional for guidance. Outdated or unnecessary medicine should not be kept. The finished commercial product is not classified as a hazardous waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azelexin found in:

A-Z Index: